Скачать или смотреть Altogen Labs PC3 Xenograft Service Prostate Cancer

Altogen Labs http://altogenlabs.com provides xenograft services http://altogenlabs.com/xenograft-mode.... The PC3 cell line is the classical and well-studied cell line for research related to human prostate cancer. It is isolated from the bone marrow metastasis of a 62-year-old Caucasian male patient with prostate cancer, treated by androgen suppression therapy. Due to its high ability to metastasize, the PC-3 cell line is an excellent host for multiple biomedical applications.
The PC3 human prostate cell line is used to create the CDX (Cell Line Derived Xenograft) PC3 xenograft mouse model that allows preclinical assessment of tumor growth suppression by statins or chemotherapies. Preclinical studies of prostate cancer can help researchers to investigate its correlation with immune response and find new therapies for patients with this disease.
Xenografting is the transplantation of tissue from one species into another.
Xenografting has been established as benchmark studies in pre-clinical cancer research.
Typically, immunodeficient mice serve as hosts for a wide variety of human tumors, effectively serving as models for human subjects.
Xenografting is a complete and accurate study of tumor growth and the activity of drug administration.
 

-PC3 Xenograft Study
Data Endpoints
Estimated tumor volume (L x W2 /2)
Mean/median time to specified tumor volume
Survival time to specified tumor volume
Tumor doubling time
Tumor growth inhibition (TGI)
Tumor growth delay (TGD)
Increased life span (ILS)
Tumor cell kill rate

-PC3 Xenograft Model
Advantages of Xenografting
Develop new therapeutic agents quickly, efficiently and cost-effectively
Evaluate the efficacy and toxicity of potential therapeutic agents
Evaluate target compound activity using in vivo system (human cells)
Predict cytotoxicity of cancer drugs

-PC3 Xenograft Model
Basic Xenograft Study
Xenograft studies can be designed to:
Identify lead compounds
Optimize dose schedules
Identify combination strategies

-PC3 Xenograft Model
Routes of drug administration:
Intratumoral
Intramuscular
Oral gavage
Intravenous
Intratracheal
Subcutaneous
Intraperitoneal
Continuous infusion
Intranasal
Using cutting-edge micro-injection techniques

-PC3 Xenograft Model
Following options are available for the PC3 xenograft model:
PC3 Tumor Growth Delay (TGD; latency)
PC3 Tumor Growth Inhibition (TGI)
Dosing frequency and duration of dose administration
PC3 tumor immunohistochemistry
Alternative cell engraftment sites (orthotopic transplantation, tail vein injection and left ventricular injection for metastasis studies, injection into the mammary fat pad, intraperitoneal injection)
Blood chemistry analysis
Toxicity and survival (optional: performing a broad health observation program)
Gross necropsies and histopathology
Positive control group employing cyclophosphamide, at a dosage of 50 mg/kg administered by intramuscular injection to the control group daily for the study duration
Lipid distribution and metabolic assays
Imaging studies: Fluorescence-based whole body imaging, MRI

-PC3 Xenograft Model
Altogen Labs’ team of scientists carries extensive experience in Xenograft model research.
Altogen Labs is compliant as a Good Laboratory Practices (GLP) environment, which is required by the FDA for pre-clinical research.
Our Altogen Labs’ Xenograft services are extensive, rigorous, and flexible.
Contact us to discuss Xenograft model details, timeline estimates, and price quotes!

Connect to Altogen Labs:
LinkedIn -   / altogen-labs  
Twitter - https://twitter.com/altogen?lang=en
Facebook -   / altogen.cro